Paul A. Carpenter

Treatment of chronic graft-versus-host disease: Past, present and future

Stephanie J. Lee, M. Flowers, P. Carpenter, 2011, The Korean journal of hematology.

Psoralen and ultraviolet A irradiation (PUVA) as therapy for steroid-resistant cutaneous acute graft-versus-host disease.

R. Storb, W. Leisenring, F. Appelbaum, 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Initial therapy of acute graft-versus-host disease with low-dose prednisone does not compromise patient outcomes.

B. Storer, M. Boeckh, M. Flowers, 2009, Blood.

Incidence, risk factors, and outcomes of sclerosis in patients with chronic graft-versus-host disease.

B. Sandmaier, B. Storer, Stephanie J. Lee, 2013, Blood.

Treatment of chronic graft-versus-host disease: Past, present and future

Stephanie J. Lee, M. Flowers, P. Carpenter, 2011, The Korean journal of hematology.

Sirolimus in combination with cyclosporine or tacrolimus plus methotrexate for prevention of graft-versus-host disease following hematopoietic cell transplantation from unrelated donors.

H. Deeg, R. Storb, F. Appelbaum, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Late effects among pediatric patients followed for nearly 4 decades after transplantation for severe aplastic anemia.

B. Storer, A. Woolfrey, M. Flowers, 2011, Blood.

Recipient and donor age impact the risk of developing chronic GvHD in children after allogeneic hematopoietic transplant

B. Storer, M. Flowers, P. Martin, 2017, Bone Marrow Transplantation.